---
search:
  boost: 2 
---

# Anti-Emetics

This is a subcategory of Gastrointestinal Agents.

## Formulary

Gastrointestinal Agents: Anti-Emetics

### Preferred

| Preferred                   | Generic Name | Quantity | Time (Days) |
| :-------------------------- | :----------- | :------: | :---------: |
| Aprepitant 40mg, 125 MG     |              |          |             |
| Diclegis <sup>BvG</sup>     |              |          |             |
| Dimenhydrinate              |              |          |             |
| Diphenhydramine             |              |          |             |
| Emend 125mg Susp            |              |          |             |
| Emend 80 MG <sup>BvG</sup>  |              |          |             |
| Emend TriPac <sup>BvG</sup> |              |          |             |
| Meclizine                   |              |          |             |
| Metoclopramide              |              |          |             |
| Ondansetron                 |              |          |             |
| Phosphorated Carbohydrate   |              |          |             |
| Prochlorperazine            |              |          |             |
| Promethazine                |              |          |             |
| Scopolamine                 |              |          |             |
| Trimethobenzamide           |              |          |             |

### Non-Preferred

| Non-Preferred                   | Generic Name | Quantity | Time (Days) |
| :------------------------------ | :----------- | :------: | :---------: |
| Aprepitant 80 mg                |              |          |             |
| Aprepitant TriPac               |              |          |             |
| Bonjesta                        |              |          |             |
| Doxylamine/Pyridoxine 10mg/10mg |              |          |             |
| Metoclopramide ODT              |              |          |             |
| Sancuso                         |              |          |             |
| Zuplenz                         |              |          |             |

## Length of Authorizations

365 Days

## All Authorizations

Must be prescribed in accordance with FDA approved labeling

## Non-Preferred Criteria

- Must provide documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances) **OR**
    - For any nonsolid oral dosage formulation: must provide documentation of medical necessity for why patient cannot be changed to a solid oral dosage formulation
- Must have had an inadequate clinical response of at least **7 days** with at least **one preferred** drug
    - For non-preferred extended-release formulations: must provide documentation of an inadequate clinical response with its immediate release formulation (if available)
    - For non-preferred brand names that have preferred generics: must provide documentation of an inadequate clinical response or allergy to two or more generic labelers (if available)

## Subsequent Authorization Criteria

- Must provide documentation of patient's clinical response to treatment and ongoing safety monitoring

## Links

[Criteria](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230101_UPDL%20_Criteria_APPROVED.pdf#page=62)

[Preferred Drug List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230101_UPDL_APPROVED_12.13.22.pdf#page=23)

[Quantity Limit List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230101_Ohio_Medicaid_Quantity_Document_APPROVED.pdf)
